MedAdvisor

MedAdvisor Revenue

Delisted

The The revenue of MedAdvisor (MDR.AX) as of Nov 18, 2026 is 63.00 M AUD. In the previous year, The revenue was 98.40 M AUD — a change of -35.98% (lower).

Revenue

63.00 MAUD

YoY

-35.98%

Last updated:

In 2025, MedAdvisor's sales reached 63.00 M AUD, a -35.98% difference from the 98.40 M AUD sales recorded in the previous year.

Over the last 14 years MedAdvisor grew revenue by 77.8% annually, reaching 63.00 M AUD.

The MedAdvisor Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2021
40.28 M AUD
Jan 1, 2022
67.75 M AUD
Jan 1, 2023
97.96 M AUD
Jan 1, 2024
98.40 M AUD
Jan 1, 2025
63.00 M AUD
Jan 1, 2026 (e)
110.67 M AUD
Jan 1, 2027 (e)
112.30 M AUD
Jan 1, 2028 (e)
116.44 M AUD
The MedAdvisor Revenue history
YEARRevenueYoY
est116.44 MAUD+3.69%
est112.30 MAUD+1.47%
est110.67 MAUD+75.68%
63.00 MAUD-35.98%
98.40 MAUD+0.45%
97.96 MAUD+44.60%
67.75 MAUD+68.20%
40.28 MAUD+263.84%
11.07 MAUD+20.42%
9.19 MAUD+24.32%
7.39 MAUD+50.85%
4.90 MAUD+178.13%
1.76 MAUD+25.49%
1.40 MAUD+4,581.67%
30,000.00AUD-66.67%
90,000.00AUD-25.00%
120,000.00AUD+500.00%
20,000.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedAdvisor Revenue

MedAdvisor Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
40.28 M AUD
-16.81 M AUD
-13.95 M AUD
Jan 1, 2022
67.75 M AUD
-16.19 M AUD
-17.35 M AUD
Jan 1, 2023
97.96 M AUD
-8.43 M AUD
-11.31 M AUD
Jan 1, 2024
98.40 M AUD
-432,800.00 AUD
792,100.00 AUD
Jan 1, 2025
63.00 M AUD
-13.06 M AUD
-60.21 M AUD
Jan 1, 2026 (e)
110.67 M AUD
-21.61 M AUD
282,782.02 AUD
Jan 1, 2027 (e)
112.30 M AUD
-21.92 M AUD
1.70 M AUD
Jan 1, 2028 (e)
116.44 M AUD
3.54 M AUD
0.00 AUD

MedAdvisor Margins

MedAdvisor stock margins

The MedAdvisor margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MedAdvisor. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MedAdvisor.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
56.64 %
-41.72 %
-34.63 %
Jan 1, 2022
51.65 %
-23.89 %
-25.60 %
Jan 1, 2023
60.64 %
-8.61 %
-11.54 %
Jan 1, 2024
54.38 %
-0.44 %
0.80 %
Jan 1, 2025
52.25 %
-20.73 %
-95.58 %
Jan 1, 2026 (e)
52.25 %
-19.52 %
0.26 %
Jan 1, 2027 (e)
52.25 %
-19.52 %
1.51 %
Jan 1, 2028 (e)
52.25 %
3.04 %
0.00 %

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Revenue Details

Understanding MedAdvisor's Sales Figures

The sales figures of MedAdvisor originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing MedAdvisor’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize MedAdvisor's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in MedAdvisor’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about MedAdvisor stock

The revenue of MedAdvisor is 63.00 M AUD in 2025.

The revenue of MedAdvisor changed from 98.40 M AUD to 63.00 M AUD, representing a -35.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The revenue MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's MedAdvisor historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MedAdvisor

All Key Metrics — MedAdvisor